As positive and negative controls, we included the high-uPAR expressing triple-negative breast cancer MDA-MB-231 cells and two uPAR-knockout (KO) KPC cell lines derived from the parental KPC cells through CRISPR RNA–guided Fokl nuclease–mediated gene editing (17). The gene discussed is PLAUR; the disease is triple-negative breast carcinoma.